An important pathway commonly dysregulated in CM patients is the angiopoietin–Tie axis, crucial to maintaining endothelial pro-barrier, anti-inflammatory, and anti-apoptotic functions (Augustin et al, 2009). This evidence concerns the gene TIE1 and cutaneous mastocytosis.